EPO and acquired polycythemia vera: When the results of existing studies are examined together with those of the current study, it appears that the PLR is a more valuable biomarker than the NLR in the diagnosis of PV, but the evidence is insufficient to recommend the use of the NLR and PLR instead of EPO.